{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/08/26/3351722/0/en/immuneering-comments-on-today-s-fda-approval-in-second-line-metastatic-pancreatic-cancer-reiterates-focus-on-first-line-patients.html", "message": "News view counter 903851 successfully enlarged"}